Evolus price target lowered to $17 from $20 at Stifel

Stifel analyst Annabel Samimy lowered the firm’s price target on Evolus (EOLS) to $17 from $20 and keeps a Buy rating on the shares following the reporting of preliminary 2025 net revenues “uncharacteristically at the low end of expectations,” tepid 2026 guidance and a meaningful cut to its prior the long-term outlook. The guidance is “conservative,” presents a “reset and clearing” and the firm thinks management has “set the stage for success,” the analyst tells investors.